Hipertrofia ventricular esquerda em pacientes com doença renal crônica em tratamento conservador
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
-
Abstract
Cardiovascular disease (CVD) remains
the major cause of death in patients with
chronic kidney disease (CKD). Left ventricular
hypertrophy (LVH) is present in
75% of patients starting dialysis, suggesting
that LVH might be present from
an early stage of CKD. Few studies have
addressed the predialysis prevalence of
LVH. This study evaluated 309 clinically
stable patients under treatment for at least
three months at five Brazilian centers. Biochemical
profile and inflammatory markers
were assessed. Data were shown as
mean ± SD. Left ventricular hypertrophy
was present in 53% of the patients, whose
mean age was 60 ± 13years. The mean age
of those without LVH was 55 ± 14 years.
Diabetes mellitus was the underlying disease
in 35% of the patients in both groups.
Estimated glomerular filtration rate was 30
± 11 and 32 ± 12 mL/min for patients with
and without LVH, respectively (p = 0.19).
The distribution of patients showed that
60% of those with LVH were in stage 4.
Multivariate logistic regression analysis
indicated the following independent determinants
for LVH: age (p < 0.001); calcium
(p < 0.001); hemoglobin (p < 0.048); and
diastolic blood pressure (p < 0.001). Systolic
blood pressure, lipids, and inflammatory
markers showed no correlation with
LVH. In conclusion, the incidence of LVH
was high even among patients under conservative
treatment, and, except for age,
LVH correlated with reversible factors.
The need for strictly diagnosing CKD and
preventing LVH in the predialysis phase is
emphasized to decrease mortality due to
CVD in that population.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
